News We’re Watching: SALSA Reintroduced, FDA Approves Abbott Valve, Metallic Implant Study
A bill aimed at preventing laboratory reimbursement cuts has been reintroduced in the US Congress. Additionally, an Abbott valve landed FDA approval, On Target Labs reported trial results, and the FDA warned that dental palate expanders may pose health risks to adults.
You may also be interested in...
The FDA’s Anesthesiology and Respiratory Therapy Devices advisory panel met to discuss racial and skin-pigmentation bias in pulse oximeter devices as well as recommendations for the agency.
The trade group is suing to get HHS to revise its method for setting laboratory payments to better reflect higher fees paid by hospital-based facilities. The case now goes back to district court.
On Target Laboratories’ Cytalux (pafolacianine) is now approved for adult patients with ovarian cancer as an adjunct for intraoperative identification of malignant lesions.